NCT00133341View on ClinicalTrials.gov

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2005

Conditions
Allergic Contact Dermatitis
Interventions
DRUG

Goldnatriomthiosulphate, MDBGN, parthenolide

Trial Locations (1)

5000

Odense University Hospital, Odense

Sponsors
All Listed Sponsors
lead

Mekos Laboratories AS

INDUSTRY